Company Filing History:
Years Active: 1985-1986
Title: Herbert Muesch: Innovator in Neuroleptic Compounds
Introduction
Herbert Muesch is a notable inventor based in Wennigsen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of neuroleptic compounds. With a total of 3 patents to his name, Muesch's work has had a considerable impact on medical science.
Latest Patents
Muesch's latest patents include innovative compounds such as isomeric 2-chloromethyl-1,4-benzodiazepine and [1,2]-fused 1,4-benzodiazepine compounds. These compounds are characterized by a general formula that includes various substituents, showcasing their potential for diverse applications. The compounds exhibit neuroleptic properties and are presented in forms that may include their optical isomers or acid addition salts. Additionally, processes for preparing these compounds and pharmaceutical compositions containing them are also disclosed in his patents.
Career Highlights
Herbert Muesch is associated with Kali-Chemie Pharma GmbH, where he continues to advance his research and development efforts. His work in the pharmaceutical industry has been instrumental in creating new therapeutic options for patients.
Collaborations
Muesch has collaborated with notable colleagues such as Horst Zeugner and Michael Ruhland, contributing to a dynamic research environment that fosters innovation.
Conclusion
Herbert Muesch's contributions to the field of neuroleptic compounds highlight his role as a significant inventor in the pharmaceutical industry. His patents reflect a commitment to advancing medical science and improving patient care.